Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy

Fan Yang(University of Pennsylvania), Yi Fan(University of Pennsylvania)
Science Translational Medicine
February 15, 2023
10.1126/scitranslmed.abq3558
Cited by 60

Related Papers

Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
|Nature Communications|2018|290
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
|Nature Communications|2018|153
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
|Nature Communications|2021|151
c-Met–mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma
|Journal of Clinical Investigation|2016|123